Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
分解axsome therapeutics: 19位分析师分享他们的观点
The standing of Axsome Therapeutics among financial experts becomes...In the preceding three months, 19 analysts have released ratings for Axsome Therapeutics (NASDAQ:AXSM), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，19位分析师发布了对Axsome Therapeutics（纳斯达克: AXSM）的评级，展示了从看好到看淡的多种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $128.05, a high estimate of $180.00, and a low estimate of $95.00. This current average has increased by 0.5% from the previous average price target of $127.41.
分析师分析的12个月目标价格提供了洞见，平均目标为128.05美元，高估为180.00美元，低估为95.00美元。当前平均值比之前的127.41美元上涨了0.5%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
The standing of Axsome Therapeutics among financial experts becomes...
通过对最近分析师行...
登录免费看全文
登录/注册
资讯热榜
更新时间